Scientific policies and ethical economies in the development of vaccines against Zika

Bibliographic Data

ID3072754
AuthorsRosana Castro (0000-0002-1069-4785, Universidade do Estado do Rio de Janeiro, corresponding author), Fleischer (0000-0002-7614-1382, Universidade de Brasília)
Year2020
Volume22
Issue2
Pages63-95
Publication date2020-11-23
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueIlha Revista de Antropologia (JOURNAL)
Journal identifiersISSN: 1517-395X • E-ISSN: 2175-8034
PublisherUniversidade Federal de Santa Catarina (UFSC) (PUBLISHER)
DOI10.5007/2175-8034.2020v22n2p63
OpenAlexW3110146605
LanguageEN
Citations received3
References cited10

The Zika epidemic alarmed international health authorities, who responded by calling for efforts to develop a vaccine. The goal was to produce a biotechnology that would especially protect pregnant women and women of reproductive age, in order to prevent more babies from developing the Congenital Zika Syndrome. In this context, scientists' arguments about the need to include pregnant women in biomedical studies have been intensified as a means of ensuring that this group receives drugs with proven safety and efficacy. Here, we prioritize the perceptions of women from two states in Brazil about their hypothetical participation in a vaccine trial against Zika. Considering their hesitations concerning medical experiments and their hopes for developing a treatment for Zika, we strain the production of biotechnologies based on specific perceptions about body, risk and ethics that neglect the knowledge of the same women they are, supposedly, seeking to protect

Context (archaeology · Developing country · Development economics · Economic growth · Economics · Environmental health · Geography · Microcephaly · Neglect · Political science · Psychiatry · Zika virus · Global Maternal and Child Health · Innovation and Socioeconomic Development · Medicine · Mosquito-borne diseases and control · Pediatrics · Virology

Tools

Open DOIOpen Access